Dsm

DSM builds algal portfolio to help meet the growing demand for omega-3

18-Jan-2023 By Stephen Daniells

DSM is expanding its algal omega-3 portfolio, driven by a gradual convergence in prices between fish and algal oil, and a focus on sustainability.

Vitafoods Asia 2022

Data delivery: DSM’s new micronutrient database aims at cost-saving, more efficient NPD

02-Nov-2022 By Tingmin Koe

DSM has developed a database that could identify the key micronutrient gaps in 11 markets across Asia-Pacific, and in turn, help health supplement brands and manufacturers design products to meet these needs.

Can DSM Firmenich merger deliver on its synergistic promise?

08-Jun-2022 By Shane Starling

DSM and Firmenich’s mooted 2023 ‘Merger of Equals’ will create a nutrition, food ingredients and fragrances behemoth with 277 years of collective business experience and a combined annual revenue pushing towards €12 billion (£10.2bn).

DSM, UNICEF, Sight and Life extends pact to address malnutrition

13-May-2022 By Will Chu

Nutrition giants DSM have renewed their partnership with UNICEF and nutrition think tank and incubator Sight and Life that seeks to improve nutrition for at-risk groups in Sub Saharan Africa and Asia.

PEOPLE ON THE MOVE

Industry Movers: DSM, Arjuna and ADM

12-Apr-2022 By Will Chu

The ‘great resignation’ appears to continue unabated with the nutrition industry being no exception. Here, NutraIngredients rounds up the moves made for March and April.

DSM hails specialised nutrition as answer to reducing elderly malnutrition

09-Dec-2021 By Nicola Gordon-Seymour

Age-related loss of appetite (or anorexia of ageing) is a primary cause of malnutrition in the elderly, which has a direct impact on the body’s ability to fight infections in later life, according to a DSM Whitepaper ‘Supporting optimal immune function...

DSM cultivates plant protein interests with €65m Vestkorn Milling buy

01-Dec-2021 By Will Chu

DSM continue to develop its interests in plant-based proteins as the corporation confirms the purchase of pea and bean ingredient specialists Vestkorn Milling for €65m.

EFSA Panel rules on trio of supplement ingredients

26-Jul-2021 By Will Chu

The European Food Safety Authority (ESFA) has taken the month of July to give its scientific opinion on a number of dietary supplement ingredients following requests from the European Commission.

DSM teams up with Debut Biotech on next generation ‘cell-free’ biomanufacturing

06-May-2021 By Elaine Watson

Ingredients giant DSM has teamed up with San Diego-based startup Debut Biotech to explore the potential of its ‘cell-free’ biomanufacturing platform, a next-generation manufacturing process it claims could unlock new opportunities to biosynthesize a far...

Culturelle unveils medical food for IBS support

19-Apr-2021 By Danielle Masterson

Culturelle Probiotics has just entered the medical food market by introducing Culturelle IBS Complete Support.

DSM launches personalized health tech company

08-Apr-2021 By Danielle Masterson

Royal DSM has announced Hologram Sciences, a consumer-facing company that will create brands that target various health conditions.

DSM purchases Amyris' biotech flavours and fragrances for €128m

31-Mar-2021 By Nikki Hancocks

DSM has today (31 March) agreed to acquire the flavour and fragrance (F&F) business of US-based biotech firm Amyris, extending its portfolio with bio-based ingredients for the flavor and fragrance and cosmetics industries.

Rubber meets the road: DSM backs cycling to boost personalised nutrition

11-Dec-2020 By Shane Starling

With the digi-ink still drying on its freshly minted pro cycling sponsorship, nutritionals giant Royal DSM is demonstrating its commitment to sports nutrition and personalised nutrition.

DSM establishes 'co-innovator' positioning with purpose-led campaign

11-Nov-2020 By Nikki Hancocks

DSM is rolling out a ‘Products with Purpose’ campaign to communicate its commitment to providing holistic health focused end-to-end solutions.

Gut simulation expands health benefits of HMOs in adults

28-Sep-2020 By Stephen Daniells

The potential health effects of human milk oligosaccharides (HMOs) for adults may extend beyond just promoting the growth of beneficial Bifidobacteria to also impacting immune function and the gut barrier, says a new study.

Resveratrol supplementation may lower average blood sugar levels, study finds

19-Jun-2020 By Will Chu

Resveratrol supplementation appears to lower values that measure average blood sugar levels over a period of time, according to a Dutch research team.

DSM Venturing backs mulberry leaf ingredient in €10m funding round

14-May-2020 By Will Chu

DSM Venturing has taken part in a €10m funding round that backs the efforts of British life science company Phynova and its mulberry leaf extract ingredient that addresses blood glucose levels.

COVID-19: China retailers and suppliers report surge in demand for Vitamin C supplements

09-Mar-2020 By Guan Yu Lim

Chinese e-commerce giant, JD has reported that sales of vitamin C dietary supplements on its platform were up five-fold, after the announcement of the novel coronavirus (COVID-19).

DSM acquires HMO firm Glycom in €765m deal

25-Feb-2020 By Will Chu

Royal DSM has reached agreement to acquire Danish Human Milk Oligosaccharide (HMO) supplier Glycom in a deal worth €765m.

‘Setting new standards’ DSM China extends summer shut down at vitamin C site for additional upgrades

18-Jul-2019 By Guan Yu Lim

DSM will extend the annual summer shut down period at its Jiangshan vitamin C site in China so further upgrades to the facility can be carried out.

NEWS IN BRIEF

DSM benefits from temporary vitamin price effect while raising 2018 outlook

09-May-2018 By Mary Ellen Shoup

DSM reported above market volume and sales gains for Q1 2018 with strong performance in its underlying nutrition business, which grew 5% in volume compared to the same period last year driven by strong sales in its i-Health and vitamin pre-mix businesses....

DSM finishes sale of pharma assets to US firm

30-Aug-2017 By Hank Schultz

DSM has completed a major milestone in its restructuring into a smaller, more profitable and more focused company as it finalized the sale of its pharmaceutical manufacturing assets to US-based Thermo Fisher Scientific Inc.

'We've made big pills a thing of the past.'

Big investment, small pills: DSM invests €27m in omega-3 technology

12-Oct-2016 By Annie Harrison-Dunn

DSM has invested over €27 million in its ‘3C technology’ which concentrates DHA and EPA up to 85% and helps reduce capsule size by up to three times.

NCN says 'curated' list helps boost success of innovation events

29-Aug-2016 By Hank Schultz

Nutrition Capital Network partner Grant Ferrier said the mentoring program his company provides has boosted the success of innovation partnership programs such as the one sponsored by DSM.

DSM stays in leader zone of Dow Jones sustainability index

23-Sep-2015 By Eliot Beer

DSM has been named as one of its sector’s leaders in environmental prudence in the Dow Jones Sustainability World Index, but the company says it sees such lists as a means, not an end.

DSM debuts enzyme ingredient designed to break down residual gluten

22-Jul-2015 By Hank Schultz

Consumers who are seeking to limit their exposure to gluten have another line of defense in a new product released by DSM. Called Tolerase G, the enzyme can serve to break down residual gluten in a meal before it can cause a reaction, the company said.

DSM backs natural zeaxanthin with exclusive deal

01-Oct-2014 By Shane STARLING

DSM, previously focused on synthetic zeaxanthin, has launched a natural version sourced from longtime carotenoid partner Kemin.

DSM to increase omega-3s capacity in light of dietary reference intake review

28-Aug-2014 By Hank Schultz

The move by Canadian and US health authorities to look at the establishment of a dietary reference intake for omega-3s will be a boon both for public health and the health of the market for these important nutrients, omega-3s supplier DSM says. The company...

DSM flexing its acquisition muscles at IFT

10-Jun-2014 By Hank Schultz

DSM will highlight all the recent additions to its royal crest at IFT. The multinational food, beverage and supplement ingredient supplier will in particular be featuring its life’s DHA ingredient at the Institute of Food Technologists show in New Orleans...

Dispatches from Vitafoods Europe 2014

Omega-3’s newest big fish reveals sector ambitions

15-May-2014 By Shane STARLING

Mid-last year the chief of Norwegian omega-3 player EPAX told us, “We are the last of the big omega-3 independents.” Soon after US agri-food company FMC had snapped it up for $350m. Here FMC Nutraceuticals general manager Daniel H. Rosenbaum talks through...

Natural astaxanthin group’s questioning of synthetic astaxanthin quality met with strong DSM defense

11-Apr-2014 By Stephen Daniells and Shane Starling

The Natural Algae Astaxanthin Association (NAXA) has again questioned the quality and regulatory status of DSM’s synthetic astaxanthin ingredient, with new data reportedly showing ‘vastly inferior antioxidant potential’ compared with the natural, algae-derived...

DSM holds first-ever call for innovation partners

03-Apr-2014 By Maggie Hennessy

In an effort to jumpstart growth in new product development, ingredients giant DSM is hosting its inaugural Innovation Partnering Conference at its Parsippany, NJ, headquarters in June.

DSM profits rise 27% but nutrition space ‘sluggish’ as omega-3 bites

05-Nov-2013 By Shane STARLING

DSM has delivered a Q3 increase in EBITDA earnings of 27% across all its divisions despite “headwinds” like the ongoing economic flatline in Europe and elsewhere, challenging currency movements and rising ingredient costs.

Nutrition division drives DSM Q2 profits up 19%

06-Aug-2013

Organic growth and a healthy boost from last year’s €500m Fortitech investment lifted Q2 pre-tax profits 19% to €345m at Dutch ingredients and chemicals giant, Royal DSM.

DSM eyes generic omega-3 drug space with €420m ONC buy

18-May-2012 By Shane Starling

DSM will use its global reach to drive its latest acquisition - fish-sourced omega-3 leader, Ocean Nutrition Canada, beyond its core North American market – but sees opportunities in generic drugs that may prove more lucrative.

Martek name to disappear as DSM creates new Nutritional Lipids business

12-Sep-2011 By Elaine Watson

Seven months after sealing a billion dollar deal to acquire Martek, DSM has created Nutritional Lipids, a new division that will combine Martek’s algal omega-3 and omega-6 products and DSM Nutritional Products’ polyunsaturated fatty acid (PUFA) portfolio.

DSM opens state-of-the-art innovation center in Parsippany, NJ

23-May-2011 By Elaine Watson

DSM has opened a new multi-million-dollar state-of-the-art nutrition innovation center in Parsippany, New Jersey, at the US headquarters of its Nutritional Products business.

DSM increases vitamin prices as costs, inflation and exchange rates bite

24-Mar-2011 By Jess Halliday

DSM is increasing the price of its vitamin B2 and B6 by 15 per cent due to a confluence of market factors: higher costs of raw materials, inflation, and inclement exchange rates. Vitamin E, A and Calpan (calcium pantothenate) prices are also rising by...

DSM agrees to modify i-flex advertising to reflect NAD recommendations

17-Jan-2011 By Stephen Daniells

DSM has agreed to modify its advertising and marketing for the i-flex joint health ingredient following recommendations from the National Advertising Division of the Council of Better Business Bureaus.

Special Edition: Antioxidants

Supply: Beta-carotene club and beyond

17-Feb-2010 By Jane Byrne

In the second part of our antioxidants special, NutraIngredients focuses on the carotenoids where the vitamin A converter, beta-carotene, is still lording it over lutein and lycopene and DSM and BASF’s synthetic versions continue to dominate that particular...

Dispatches from Health Ingredients Europe